Clinical Trial Update: Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating octreotide for sulfonylurea-associated hypoglycemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypoglycemia

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: Albert Einstein Healthcare Network | Conditions: Hypoglycemia, Diabetes Mellitus | Phase 3 | Status: COMPLETED